Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review

Neuroepidemiology - Tập 23 Số 4 - Trang 159-169 - 2004
Christine A. Szekely1, Jennifer E. Thorne1,2, Peter P. Zandi1, Mats Ek1, Erick Messias1, John C.S. Breitner3, Steven N. Goodman1,2
1Johns Hopkins Bloomberg School of Public health
2Johns Hopkins School of Medicine, Baltimore, Md., and
3VA Puget Sound Health Care System and University of Washington School of Medicine, Seattle, Wash., USA

Tóm tắt

<i>Objective:</i> Alzheimer’s disease, the most prevalent dementia, is a prominent source of chronic illness in the elderly. Laboratory evidence suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) might prevent the onset of Alzheimer’s disease. Since the early 1990s, numerous observational epidemiological studies have also investigated this possibility. The purpose of this meta-analysis is to summarize and evaluate available evidence regarding exposure to nonaspirin NSAIDs and risk of Alzheimer’s disease using meta-analyses of published studies. <i>Methods:</i> A systematic search was conducted using Medline, Biological Abstracts, and the Cochrane Library for publications from 1960 onwards. All cross-sectional, retrospective, or prospective observational studies of Alzheimer’s disease in relation to NSAID exposure were included in the analysis. At least 2 of 4 independent reviewers characterized each study by source of data and design, including method of classifying exposure and outcome, and evaluated the studies for eligibility. Discrepancies were resolved by consensus of all 4 reviewers. <i>Results: </i>Of 38 publications, 11 met the qualitative criteria for inclusion in the meta-analysis. For the 3 case-control and 4 cross-sectional studies, the combined risk estimate for development of Alzheimer’s disease was 0.51 (95% CI = 0.40–0.66) for NSAID exposure. In the prospective studies, the estimate was 0.74 (95% CI = 0.62–0.89) for the 4 studies reporting lifetime NSAID exposure and it was 0.42 (95% CI = 0.26–0.66) for the 3 studies reporting a duration of use of 2 or more years. <i>Conclusions: </i>Based on analysis of prospective and nonprospective studies, NSAID exposure was associated with decreased risk of Alzheimer’s disease. An issue that requires further exploration in future trials or observational studies is the temporal relationship between NSAID exposure and protection against Alzheimer’s disease.

Từ khóa


Tài liệu tham khảo

10.1111%2Fj.1749-6632.2000.tb05554.x

10.1002%2F%28SICI%291097-0258%2820000615%2F30%2919%3A11%2F12%3C1481%3A%3AAID-SIM440%3E3.0.CO%3B2-U

10.1056%2FNEJM200111223452110

10.1016%2FS0140-6736%2896%2903356-9

10.1001%2Fjama.288.17.2123

10.1023%2FA%3A1007614613771

10.1016%2F0197-4580%2895%2900049-K

10.1016%2F0140-6736%2890%2991101-F

10.1093%2Frheumatology%2F33.5.501

10.1093%2Frheumatology%2F28.1.86-b

10.1159%2F000107010

10.1001%2Fjama.289.21.2819

10.1016%2FS0197-4580%2801%2900297-4

10.1016%2FS0197-4580%2800%2900124-X

10.1086%2F302477

10.1016%2FS0304-3940%2800%2901294-5

10.1136%2Fbmj.327.7407.128

10.1046%2Fj.1532-5415.2001.49185.x

10.1016%2F0140-6736%2891%2993122-P

10.1002%2Fana.410280607

10.1002%2Fana.410150406

10.1016%2FS0140-6736%2801%2905667-7

10.1001%2Farchneur.57.6.831

10.1016%2FS0197-4580%2898%2900101-8

10.2165%2F00002512-199609010-00001

10.4065%2F71.3.275

10.1016%2FS0197-4580%2898%2900096-7

10.1056%2FNEJMoa010178

10.1159%2F000048621

10.1002%2F%28SICI%291099-1166%28199709%2912%3A9%3C926%3A%3AAID-GPS665%3E3.3.CO%3B2-P

10.1001%2Farchneur.58.3.517-a

10.1016%2F0006-3223%2894%2990598-3

10.1001%2Farchneur.57.11.1586

10.4065%2F73.10.951

10.1093%2Faje%2Fkwf074

10.1176%2Fappi.ajgp.11.2.179

10.1016%2FS0197-4580%2898%2900102-X

10.1001%2Fjama.262.18.2551

10.1016%2FS0140-6736%2895%2992405-1

10.1016%2F0895-4356%2896%2900202-8

10.1001%2Fjama.279.4.281

10.1016%2F0197-4580%2894%2990199-6

10.1016%2FS0197-2456%2801%2900189-1

Thông tin
Thông tin xuất bản

Neuroepidemiology

Tập 23 Số 4

159-169

Thông tin tác giả